TLDR Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.
This study evaluated the potential dementia risk associated with alpha-blockers and 5-alpha reductase inhibitors (5ARIs) in patients with benign prostatic hyperplasia (BPH) by analyzing data from 5 multicenter studies involving 3,650,434 patients. The results indicated no significant association between these medications and an increased risk of dementia. However, 5ARIs showed a relatively higher probability of dementia risk compared to other treatments. The findings suggest that these medications can be prescribed without significant concern for dementia risk, but further large-scale research is recommended to confirm these results.
December 2022 in “JAMA network open” 5α-Reductase inhibitors may increase depression risk but not dementia or suicide.
18 citations
,
June 2017 in “Journal of the neurological sciences” Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.
2 citations
,
September 2009 in “Hormone Molecular Biology and Clinical Investigation” Low dose finasteride decreases certain steroids, possibly increasing depression risk.
6 citations
,
August 2021 in “Clinical Epidemiology” Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.
1 citations
,
April 2019 in “Clinical Breast Cancer” Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.
15 citations
,
July 2016 in “Urologic Clinics of North America” Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.
15 citations
,
November 2015 in “Pharmacopsychiatry” α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.
35 citations
,
May 2020 in “Frontiers in Pharmacology” Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.